dc.creatorJalit, Yamile
dc.creatorGutierrez, Fabiana Andrea
dc.creatorDubacheva, Galina
dc.creatorGoyer, Cedric
dc.creatorCoche Guerente, Liliane
dc.creatorDefrancq, Eric
dc.creatorLabbe, Pierre
dc.creatorRivas, Gustavo Adolfo
dc.creatorRodriguez, Marcela Cecilia
dc.date.accessioned2017-10-05T18:35:14Z
dc.date.accessioned2018-11-06T13:19:49Z
dc.date.available2017-10-05T18:35:14Z
dc.date.available2018-11-06T13:19:49Z
dc.date.created2017-10-05T18:35:14Z
dc.date.issued2012-09
dc.identifierJalit, Yamile; Gutierrez, Fabiana Andrea; Dubacheva, Galina; Goyer, Cedric; Coche Guerente, Liliane; et al.; Characterization of a modified gold platform for the development of a label-free anti-thrombin aptasensor; Elsevier Science; Biosensors & Bioelectronics; 41; 9-2012; 424-429
dc.identifier0956-5663
dc.identifierhttp://hdl.handle.net/11336/26000
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1874418
dc.description.abstractThis work reports the characterization of a modified gold surface as a platform for the development of a label free aptasensor for thrombin detection. The biorecognition platform was obtained by the self-assembly of 4-mercaptobenzoic acid onto a gold surface, covalent attachment of streptavidin and further immobilization of the biotinylated anti-thrombin aptamer. The biosensing platform was characterized by cyclic voltammetry, electrochemical impedance spectroscopy, surface plasmon resonance (SPR) and quartz crystal microbalance with dissipation monitoring. The biorecognition event aptamer-thrombin was detected from changes in the SPR angle produced as a consequence of the molecular interaction between the aptasensor and the target protein. The biosensing platform demonstrated to be highly selective for human thrombin even in the presence of large excess of bovine thrombin, bovine serum albumin, cytochrome C, lysozyme and myoglobin. The relationship between the changes in the SPR angle and thrombin concentration was linear up to 0.19 μmol L−1 (R2=0.992) while the detection limit was of 12.0 nmol L−1 (240 fmol in the sample). This new sensing approach represents an interesting and promising alternative for the SPR-based quantification of thrombin.
dc.languageeng
dc.publisherElsevier Science
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bios.2012.08.061
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0956566312006021
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectThrombin binding aptamer
dc.subjectAptasensor
dc.subjectOptical aptasensor
dc.subjectThrombin biosensor
dc.subjectProtein detection
dc.subjectSPR sensing
dc.titleCharacterization of a modified gold platform for the development of a label-free anti-thrombin aptasensor
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución